BioPharma
02 November, 2026 | Monday | Analysis
APAC-Originated Obesity Drugs in the Clinic, Beyond Semaglutide
Obesity was the most searched therapeutic area of 2026, and for most readers the story still has two names in it. Semaglutide and tirzepatide set the benchmarks, the prices and the supply headlines. Yet the pip...
Lab
20 October, 2026 | Tuesday | News
Cotecna Accelerates India Life Sciences Expansion With Acquisition of Hyderabad-Based Energon Labs
Cotecna, a leading provider of Testing, Inspection and Certification (TIC) services, announced the acquisition of Energon Labs, a cGMP-compliant, USFDA-inspected, ISO 9001:2015 and ISO 17025:2017 certifie...
BioTech
05 November, 2026 | Thursday | Analysis
APAC Antibody-Drug Conjugates Past Phase 2, and Who Owns Them Now
Seventeen of them have already been licensed outside their home market, and the companies that will sell most of them in the US and Europe are Merck, AstraZeneca, GSK, BioNTech, Roche, BMS, Pfizer and Takeda. T...
Contract Services
04 November, 2026 | Wednesday | News
Lonza to Acquire Five US CDMO Sites from Merck KGaA to Double Manufacturing Footprint
Lonza acquires five CDMO manufacturing sites and approximately 1,100 highly skilled employees, more than doubling its US footprint to nine CDMO sites with a US workforce of more than 6,000 employees. Transac...
Consumer Health
06 November, 2026 | Friday | News
Abbott and Novo Expand Collaboration to Broaden Semaglutide Access Across Asia Pacific
The collaboration combines Novo's leadership in diabetes care medicines and GLP-1 therapies with Abbott's extensive healthcare and commercial footprint across the region Abbott will promote and distribute Pl...
Medtech
06 November, 2026 | Friday | News
Abbott and Novo Expand Collaboration to Broaden Semaglutide Access Across Asia Pacific
The collaboration combines Novo's leadership in diabetes care medicines and GLP-1 therapies with Abbott's extensive healthcare and commercial footprint across the region Abbott will promote and distribute Pl...
Cell & Gene
23 October, 2026 | Friday | News
Therakos Secures EU MDR Approval for First-of-Its-Kind Therapy to Manage Cancer Immunotherapy Toxicities
Therakos Development Limited, a global pioneer in immunomodulatory therapy delivered at the bedside through extracorporeal photopheresis (ECP), announced that its THERAKOS™ CELLEX™ Photopheresis Sys...
White Paper
05 November, 2026 | Thursday | Analysis
APAC Antibody-Drug Conjugates Past Phase 2, and Who Owns Them Now
Product Spot Light
16 October, 2026 | Friday | News
Danaher and NVIDIA Join Forces to Bring Autonomous AI-Powered Science into Laboratories
Premium Article
03 November, 2026 | Tuesday | Regulatory
China's 2026 Reimbursement Lists: 10 Drugs That Will Show Where Beijing Is Paying, and the Commercial List's Second Year
Bio Invest
30 October, 2026 | Friday | News
Merck Opens €300 Million Bioprocessing Hub in South Korea to Strengthen APAC Supply Chain
Biopharma APAC Infomercial
Most Read
- Can APAC Biomanufacturing Decarbonise Without Pricing Itself Out?
- The Algorithm on the GMP Floor: AI Promises a Smarter Plant. Regulators Demand the Audit Trail.
- APAC's Peptide-Capacity Gamble
- After the Rush: APAC's mRNA and Vaccine Capacity Hangover
- The Biosimilar Race: Factory to the World — or Stuck in the Copycat Economy?
- The Vein-to-Vein Problem: Can APAC's Cold Chain Carry Advanced Therapies?
- Vectors, Plasmids and the CGT Trap: APAC's Cell and Gene Therapy Ambitions Face an Upstream Bottleneck
- Can APAC Build Radioligand Therapy Before the Atoms Decay?
- The Great Biopharma Reset: 50 Developments That Changed Everything in H1 2026
- Beyond the Trial: Can Real-World Evidence Earn Regulatory Trust in APAC?
- Beyond the Obvious Giant: Where APAC's Clinical Trials Go Next
- The Frontier That Won’t Quite Arrive
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
